19961113
 Immunex Corp.: Chemotherapy drug gets FDA approval for market   The Wall Street Journal,  Nov 14, 1996  Immunex Corp received FDA approval to market its chemotherapy drug Novantrone as a pain killer for patients with advanced prostate cancer.   
